Should Burden of Disease Estimates Include Cannabis Use as a Risk Factor for Psychosis?
Open Access
- 29 September 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 6 (9), e1000133
- https://doi.org/10.1371/journal.pmed.1000133
Abstract
Louise Degenhardt and colleagues discuss the evidence and the debate about whether Global Burden of Disease estimates should include cannabis use as a risk factor for psychosis.Keywords
This publication has 66 references indexed in Scilit:
- Effects of cannabis use on outcomes of psychotic disorders: systematic reviewThe British Journal of Psychiatry, 2008
- The occurrence and nature of early signs of schizophrenia and psychotic mood disorders among former child and adolescent psychiatric patients followed into adulthoodChild and Adolescent Psychiatry and Mental Health, 2008
- Why Current Publication Practices May Distort SciencePLoS Medicine, 2008
- Modelling disease frequency measures in schizophrenia epidemiologySchizophrenia Research, 2008
- Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophreniaInternational Journal of Neuropsychopharmacology, 2008
- Gene-Environment Interplay Between Cannabis and PsychosisSchizophrenia Bulletin, 2008
- Cannabis use and risk of psychotic or affective mental health outcomes: a systematic reviewThe Lancet, 2007
- Cannabis use and misuse prevalence among people with psychosisThe British Journal of Psychiatry, 2005
- Cannabis Use is Not Associated With the Development of Psychosis in an ‘Ultra’ High-Risk GroupAustralian & New Zealand Journal of Psychiatry, 2002
- The prevalence and relevance of substance use in detained schizophrenic patientsJournal of Forensic Psychiatry, 1998